| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 9.573.729 $ | +1.827.858 $ | +23,4 % | 6.905.059 $ | -18.280.319 $ | -71,3 % | 39.131.198 $ | +16.899.610 $ | +74,7 % | |
| RA CAPITAL MANAGEMENT, L.P. | 5.562.856 $ | +1.330.248 $ | +31,4 % | 4.232.608 $ | -8.929.567 $ | -67,8 % | 13.162.175 $ | +5.879.550 $ | +80,7 % |
| MPM ASSET MANAGEMENT LLC | 8.490.424 $ | +3.792.677 $ | +80,7 % | ||||||
| MPM BioImpact LLC | 1.006.455 $ | +122.940 $ | +13,9 % | 883.515 $ | -3.861.841 $ | -81,4 % | 4.745.356 $ | +2.119.753 $ | +80,7 % |
| BANK OF AMERICA CORP /DE/ | 466.869 $ | -3.138.806 $ | -87,1 % | 3.605.675 $ | +1.285.039 $ | +55,4 % | |||
| VANGUARD GROUP INC | 892.702 $ | -1.881.150 $ | -67,8 % | 2.773.852 $ | +1.358.758 $ | +96,0 % | |||
| SPHERA FUNDS MANAGEMENT LTD. | 521.882 $ | +124.798 $ | +31,4 % | 1.234.816 $ | +551.593 $ | +80,7 % | |||
| DC Funds, LP | 490.486 $ | +117.290 $ | +31,4 % | 1.160.531 $ | +518.410 $ | +80,7 % | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 1.014.574 $ | ||||||||
| RENAISSANCE TECHNOLOGIES LLC | 429.803 $ | +438 $ | +0,1 % | 429.365 $ | -468.955 $ | -52,2 % | 898.320 $ | +553.553 $ | +160,6 % |
| PFM Health Sciences, LP | 790.187 $ | +352.977 $ | +80,7 % | ||||||
| GEODE CAPITAL MANAGEMENT, LLC | 651.832 $ | +294.269 $ | +82,3 % | ||||||
| MILLENNIUM MANAGEMENT LLC | 624.594 $ | -134.804 $ | -17,8 % | ||||||
| Lynx1 Capital Management LP | 547.673 $ | +132.144 $ | +31,8 % | ||||||
| JANE STREET GROUP, LLC | 529.097 $ | +120.414 $ | +29,5 % | ||||||
| Alyeska Investment Group, L.P. | 464.339 $ | +207.421 $ | +80,7 % | ||||||
| 9.573.729 $ | +1.827.858 $ | +23,4 % | 6.905.059 $ | -18.280.319 $ | -71,3 % | 39.131.198 $ | +16.899.610 $ | +74,7 % | |